title: Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial.
authors.forename: A J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: M
authors.initials: M
authors.lastname: Ponzoni
authors.forename: G P
authors.initials: GP
authors.lastname: Dognini
authors.forename: M-Q
authors.initials: MQ
authors.lastname: Du
authors.forename: C
authors.initials: C
authors.lastname: Doglioni
authors.forename: J
authors.initials: J
authors.lastname: Radford
authors.forename: R
authors.initials: R
authors.lastname: Dolcetti
authors.forename: F
authors.initials: F
authors.lastname: Cavalli
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D002689:Chlamydia / Q000187:drug effects; D002986:Clinical Trials as Topic; D004318:Doxycycline / Q000494:pharmacology* / Q000627:therapeutic use*; D023381:Endpoint Determination; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000382:microbiology*; D005500:Follow-Up Studies; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy* / Q000382:microbiology*; D011446:Prospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D004318:Doxycycline